Login
$SYRE
$99.07 -$4.93 (4.74%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Cameron Turtle Also a director
Chief Executive Officer and Director
36 Not stated Not stated $6,707,361
Scott Burrows
Chief Financial Officer
49 Since 2023
3 years
2023 $2,192,045
Sheldon Sloan
Chief Medical Officer
68 Since 2024
2 years
Not stated $2,211,805
Heidy King-Jones
See Remarks
Title from the Form 4 dated Oct 1, 2026
43 Not stated 2023 $2,192,045

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 10, 2026 · updated by the 8-K of May 29, 2026

Directors
7
serving now
Independent
5 of 7
stated in the proxy
Average tenure
2.7 years
from year joined
Director Age On board Independent Other public boards 2025 pay Source
Cameron Turtle
36 2023
3 years
Not independent Damora Therapeutics, Inc. (Nasdaq: DMRA) Paid as CEO
Mark McKenna
46 2024
2 years
Not independent Apogee Therapeutics, Inc. (Nasdaq: APGE) $288,675
Laurie Stelzer
58 2023
3 years
Independent MBX Biosciences, Inc. (Nasdaq: MBX) $313,675
Jeffrey Albers
54 2023
3 years
Independent Kymera Therapeutics, Inc. (Nasdaq: KYMR) $348,675
Tomas Kiselak
39 2023
3 years
Independent Viridian Therapeutics, Inc. (Nasdaq: VRDN) $296,175
Michael Henderson
36 2023
3 years
Independent Apogee Therapeutics, Inc. (Nasdaq: APGE) $298,675
Sandra Milligan
62 2024
2 years
Independent Gossamer Bio, Inc. (Nasdaq: GOSS) $306,175

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 10, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support